Advances and Surgical Considerations in the Treatment of Moyamoya Disease.
暂无分享,去创建一个
[1] Grant W. Mallory,et al. Moyamoya Disease in a Primarily White, Midwestern US Population: Increased Prevalence of Autoimmune Disease , 2013, Stroke.
[2] C. Derdeyn,et al. Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings. , 2013, Journal of neurosurgery.
[3] D. Geng,et al. Whole-Brain CT Perfusion and CT Angiography Assessment of Moyamoya Disease before and after Surgical Revascularization: Preliminary Study with 256-Slice CT , 2013, PloS one.
[4] R. Du,et al. The natural history of Moyamoya in a North American adult cohort , 2013, Journal of Clinical Neuroscience.
[5] Rong Wang,et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[6] M. Maltenfort,et al. Moyamoya disorder in the United States. , 2012, Neurosurgery.
[7] W. Joo,et al. Prevalence and Epidemiological Features of Moyamoya Disease in Korea , 2012, Journal of cerebrovascular and endovascular neurosurgery.
[8] T. Noguchi,et al. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. , 2011, European journal of radiology.
[9] G. Steinberg,et al. Neurosurgical Advances in the Treatment of Moyamoya Disease , 2011, Stroke.
[10] S. Gazal,et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. , 2011, American journal of human genetics.
[11] Dong-Seok Kim,et al. Natural history and progression factors of unilateral moyamoya disease in pediatric patients , 2011, Child's Nervous System.
[12] R. Guzman,et al. Intraoperative Blood Flow Analysis of Direct Revascularization Procedures in Patients with Moyamoya Disease , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] A. Hata,et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.
[14] V. Larrue,et al. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease , 2010 .
[15] R. Grubb,et al. Clinical Features and Outcome in North American Adults With Idiopathic Basal Arterial Occlusive Disease Without Moyamoya Collaterals , 2010, Neurosurgery.
[16] I. Nakagawa,et al. Virtual surgical planning for superficial temporal artery to middle cerebral artery bypass using three-dimensional digital subtraction angiography , 2010, Acta Neurochirurgica.
[17] Seung-Chyul Hong,et al. Association of Thyroid Autoantibodies With Moyamoya-Type Cerebrovascular Disease: A Prospective Study , 2010, Stroke.
[18] R. Scott,et al. Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.
[19] H. Machado,et al. Effect of multiple cranial burr hole surgery on prevention of recurrent ischemic attacks in children with moyamoya disease. , 2009, Neuropediatrics.
[20] T. Tominaga,et al. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. , 2009, Surgical neurology.
[21] M. Marks,et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. , 2009, Journal of neurosurgery.
[22] M. Elkind,et al. Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. , 2009, Journal of neurosurgery.
[23] Moyamoya Phenomenon Secondary to Intracranial Atherosclerotic Disease: Diagnosis by 3T Magnetic Resonance Imaging , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[24] H. Steiger,et al. C-Port Flex-A-assisted automated anastomosis for high-flow extracranial-intracranial bypass surgery in patients with symptomatic carotid artery occlusion: a feasibility study. Clinical article. , 2009, Journal of neurosurgery.
[25] J. Miller,et al. Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease: a prospective observational study. , 2009, Neurosurgical focus.
[26] P. Berlit,et al. Moyamoya Disease in Europeans , 2008, Stroke.
[27] E. Connolly,et al. Radiographic and clinical predictors of hemodynamic insufficiency in patients with athero-occlusive disease. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[28] M. Chicoine,et al. Automated, compliant, high-flow common carotid to middle cerebral artery bypass. , 2008, Journal of neurosurgery.
[29] S. Lee,et al. Moyamoya syndrome associated with systemic lupus erythematosus , 2008, Lupus.
[30] K. Nozaki,et al. “TARGET BYPASS”: A METHOD FOR PREOPERATIVE TARGETING OF A RECIPIENT ARTERY IN SUPERFICIAL TEMPORAL ARTERY‐TO‐MIDDLE CEREBRAL ARTERY ANASTOMOSES , 2008, Neurosurgery.
[31] A. van der Zwan,et al. Excimer laser-assisted nonocclusive anastomosis. An emerging technology for use in the creation of intracranial-intracranial and extracranial-intracranial cerebral bypass. , 2008, Neurosurgical focus.
[32] T. Yoshimoto,et al. Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey , 2008, Stroke.
[33] S. Kuroda,et al. Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[34] R. Grubb,et al. Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon , 2006, Stroke.
[35] D. Tirschwell,et al. Moyamoya disease in Washington State and California , 2005, Neurology.
[36] Peter Vajkoczy,et al. Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography. , 2005, Journal of neurosurgery.
[37] Douglas J. Fox,et al. Moyamoya Disease in Adults: The Role of Cerebral Revascularization , 2005, Skull base : official journal of North American Skull Base Society ... [et al.].
[38] S. Amin-Hanjani,et al. The Cut Flow Index: An Intraoperative Predictor of the Success of Extracranial-Intracranial Bypass for Occlusive Cerebrovascular Disease , 2005, Neurosurgery.
[39] S. Kuroda,et al. Increased Expression of Hepatocyte Growth Factor in Cerebrospinal Fluid and Intracranial Artery in Moyamoya Disease , 2004, Stroke.
[40] M. Fukui,et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23 , 2004, Journal of Human Genetics.
[41] S. Miyamoto. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset--the Japan Adult Moyamoya Trial Group. , 2004, Neurologia medico-chirurgica.
[42] H. Seol,et al. Moyamoya Disease among Young Patients: Its Aggressive Clinical Course and the Role of Active Surgical Treatment , 2004, Neurosurgery.
[43] Jodi,et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. , 2004, Journal of neurosurgery.
[44] S. Kuroda,et al. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease , 2004, Child's Nervous System.
[45] P. Huh,et al. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. , 2003, Journal of Korean medical science.
[46] J. Gosalakkal. Moyamoya disease: a review. , 2002, Neurology India.
[47] A. Yamaura,et al. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. , 2000, Journal of neurosurgery.
[48] T. Sakaki,et al. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. , 2000, Journal of neurosurgery.
[49] T. Yoshimoto,et al. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study. , 1999, Stroke.
[50] M. Fukui,et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. , 1999, American journal of human genetics.
[51] T. Yoshimoto,et al. Effect of inhalational anesthesia on cerebral circulation in Moyamoya disease. , 1998, Journal of neurosurgical anesthesiology.
[52] J. Grotta,et al. Clinical features of moyamoya disease in the United States. , 1998, Stroke.
[53] Kayoko Saito,et al. Long-term outcomes of pediatric moyamoya disease monitored to adulthood. , 1998, Pediatric neurology.
[54] D. Nam,et al. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis , 1997, Clinical Neurology and Neurosurgery.
[55] M. Fukui,et al. Clinical features of probable Moyamoya disease in Japan , 1997, Clinical Neurology and Neurosurgery.
[56] K. Fujii,et al. The efficacy of bypass surgery for the patients with hemorrhagic Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.
[57] M. Fukui,et al. Epidemiological features of Moyamoya disease in Japan: findings from a nationwide survey , 1997, Clinical Neurology and Neurosurgery.
[58] S. Peerless. Risk factors of Moyamoya disease in Canada and the USA , 1997, Clinical Neurology and Neurosurgery.
[59] K. Takase,et al. Transcranial Doppler ultrasonography in patients with Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.
[60] E. Y. Kim,et al. Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups , 1997, Clinical Neurology and Neurosurgery.
[61] K. Houkin,et al. Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. , 1997, Stroke.
[62] A. Takahashi,et al. Angiogenic factors in moyamoya disease. , 1996, Stroke.
[63] M. Aoyagi,et al. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. , 1996, Stroke.
[64] H. Topka,et al. Progressive cerebral occlusive disease after radiation therapy. , 1995, Stroke.
[65] H. Hoshi,et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] H. Adams,et al. Cerebral infarction due to moyamoya disease in young adults. , 1988, Stroke.
[67] Y. Fukuyama,et al. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of willis (“Moyamoya” disease) in children , 1985, Brain and Development.
[68] K. Hasuo,et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. , 1985, Pediatric neurology.
[69] N. Lenn,et al. Moyamoya and other causes of stroke in patients with Down syndrome. , 1985, Pediatric neurology.
[70] N. Kodama,et al. Moyamoya disease‐‐a review. , 1983, Stroke.
[71] J. Woolliscroft,et al. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis , 1980, Clinical genetics.
[72] J. Parker,et al. Dilated Episcleral Arteries — a Significant Physical Finding in Assessment of Patients with Cerebrovascular Insufficiency Cerebrovascular Disease in Sickle Cell Anemia: a Clinical, Pathological and Radiological Correlation , 2022 .
[73] A Takaku,et al. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.
[74] R. Donaghy,et al. Microangeional surgery and its techniques. , 1968, Progress in brain research.